Glenmark Pharmaceuticals
GLENMARK.NS
#2590
Rank
NZ$9.34 B
Marketcap
$33.09
Share price
0.55%
Change (1 day)
106.90%
Change (1 year)

Glenmark Pharmaceuticals (GLENMARK.NS) - Total debt

Total debt on the balance sheet as of March 2024 : NZ$0.24 Billion

According to Glenmark Pharmaceuticals 's latest financial reports the company's total debt is NZ$0.24 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Glenmark Pharmaceuticals - Total debt on balance sheet (from 2012 to 2024)

Total debt by year

Year Total debt Change
2023-03-31NZ$0.89 B19.93%
2022-03-31NZ$0.74 B-22.79%
2021-03-31NZ$0.97 B-15.17%
2020-03-31NZ$1.14 B21.51%
2019-03-31NZ$0.94 B-4.29%
2018-03-31NZ$0.98 B-5.47%
2017-03-31NZ$1.04 B19.59%
2016-03-31NZ$0.87 B7.41%
2015-03-31NZ$0.81 B28.68%
2014-03-31NZ$0.62 B3.52%
2013-03-31NZ$0.60 B13.13%
2012-03-31NZ$0.53 B-13.29%
2011-03-31NZ$0.62 B5.08%
2010-03-31NZ$0.59 B-19.83%
2009-03-31NZ$0.73 B132.61%
2008-03-31NZ$0.31 B4.38%
2007-03-31NZ$0.30 B12.71%
2006-03-31NZ$0.26 B91.08%
2005-03-31NZ$0.14 B254.1%
2004-03-31NZ$39.76 M